Hyponatremia natural history, complications and prognosis: Difference between revisions

	Hyponatremia Microchapters
Home
Patient information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hyponatremia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiogram or Ultarsound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hyponatremia natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hyponatremia natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hyponatremia natural history, complications and prognosis
CDC on Hyponatremia natural history, complications and prognosis
Hyponatremia natural history, complications and prognosis in the news
Blogs on Hyponatremia natural history, complications and prognosis
Directions to Hospitals Treating hyponatremia
Risk calculators and risk factors for Hyponatremia natural history, complications and prognosis

← Older edit Newer edit →

VisualWikitext

Revision as of 20:42, 31 January 2018

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

OR

Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].

OR

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.

Natural History, Complications, and Prognosis

Natural History

The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
The symptoms of (disease name) typically develop ___ years after exposure to ___.
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

Complications

Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]

Prognosis

Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
[Subtype of disease/malignancy] is associated with the most favorable prognosis.
The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

References

Template:WH Template:WS

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Hyponatremia}}
-{{CMG}}
-Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
+{{CMG}}; {{AE}}
-==Complications==
-Neurological (brain) symptoms typically occur with very low levels of plasma sodium (usually <115 mEq/L). When sodium levels in the blood become excessively low, excess water enters the brain cells and the cells swell. This is called hyponatremic encephalopathy.<ref name="Fraser-1997">{{Cite journal  | last1 = Fraser | first1 = CL. | last2 = Arieff | first2 = AI. | title = Epidemiology, pathophysiology, and management of hyponatremic encephalopathy. | journal = Am J Med | volume = 102 | issue = 1 | pages = 67-77 | month = Jan | year = 1997 | doi =  | PMID = 9209203 }}</ref>
+==Overview==
+If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
+OR
+Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
+OR
+Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
+==Natural History, Complications, and Prognosis==
+===Natural History===
+*The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
+*The symptoms of (disease name) typically develop ___ years after exposure to ___.
+*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
+===Complications===
+*Common complications of [disease name] include:
+**[Complication 1]
+**[Complication 2]
+**[Complication 3]
+===Prognosis===
+*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
+*Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
+*The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
+*[Subtype of disease/malignancy] is associated with the most favorable prognosis.
+*The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
 ==References==
 {{Reflist|2}}
-[[Category:Needs content]]
-[[Category:Electrolyte disturbance]]
-[[Category:Nephrology]]
-[[Category:Blood tests]]
-[[Category:Emergency medicine]]
-[[Category:Intensive care medicine]]
 {{WH}}
 {{WS}}
+[[Category: (name of the system)]]